Author Correction: Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique.
Saved in:
| Title: | Author Correction: Antibody responses to the RTS,S/AS01 |
|---|---|
| Authors: | Sánchez L; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.; UnivLyon, Université Claude Bernard Lyon 1, 69100, Villeurbanne, France., Vidal M; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain., Jairoce C; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Aguilar R; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain., Ubillos I; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain., Cuamba I; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Nhabomba AJ; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Williams NA; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain., Díez-Padrisa N; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain., Cavanagh D; Institute of Immunology & Infection Research and Centre for Immunity, Infection & Evolution, Ashworth Laboratories, School of Biological Sciences, University of Edinburgh, King's Buildings, Edinburgh, UK., Angov E; U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA., Coppel RL; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne, VIC, Australia., Gaur D; Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.; Laboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India., Beeson JG; Burnet Institute, Melbourne, VIC, Australia., Dutta S; U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA., Aide P; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Campo JJ; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Moncunill G; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain. gemma.moncunill@isglobal.org.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique. gemma.moncunill@isglobal.org., Dobaño C; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain. carlota.dobano@isglobal.org.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique. carlota.dobano@isglobal.org. |
| Source: | NPJ vaccines [NPJ Vaccines] 2022 Aug 08; Vol. 7 (1), pp. 91. Date of Electronic Publication: 2022 Aug 08. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35941348 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Antibody responses to the RTS,S/AS01<subscript>E</subscript> vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sánchez+L%22">Sánchez L</searchLink>; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.; UnivLyon, Université Claude Bernard Lyon 1, 69100, Villeurbanne, France.<br /><searchLink fieldCode="AU" term="%22Vidal+M%22">Vidal M</searchLink>; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Jairoce+C%22">Jairoce C</searchLink>; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Aguilar+R%22">Aguilar R</searchLink>; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Ubillos+I%22">Ubillos I</searchLink>; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Cuamba+I%22">Cuamba I</searchLink>; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Nhabomba+AJ%22">Nhabomba AJ</searchLink>; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Williams+NA%22">Williams NA</searchLink>; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Díez-Padrisa+N%22">Díez-Padrisa N</searchLink>; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Cavanagh+D%22">Cavanagh D</searchLink>; Institute of Immunology & Infection Research and Centre for Immunity, Infection & Evolution, Ashworth Laboratories, School of Biological Sciences, University of Edinburgh, King's Buildings, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Angov+E%22">Angov E</searchLink>; U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Coppel+RL%22">Coppel RL</searchLink>; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Gaur+D%22">Gaur D</searchLink>; Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.; Laboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Beeson+JG%22">Beeson JG</searchLink>; Burnet Institute, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Dutta+S%22">Dutta S</searchLink>; U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Aide+P%22">Aide P</searchLink>; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Campo+JJ%22">Campo JJ</searchLink>; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Moncunill+G%22">Moncunill G</searchLink>; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain. gemma.moncunill@isglobal.org.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique. gemma.moncunill@isglobal.org.<br /><searchLink fieldCode="AU" term="%22Dobaño+C%22">Dobaño C</searchLink>; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain. carlota.dobano@isglobal.org.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique. carlota.dobano@isglobal.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101699863%22">NPJ vaccines</searchLink> [NPJ Vaccines] 2022 Aug 08; Vol. 7 (1), pp. 91. <i>Date of Electronic Publication: </i>2022 Aug 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+in+partnership+with+the+Sealy+Center+for+Vaccine+Development%22">Springer Nature in partnership with the Sealy Center for Vaccine Development </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101699863 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-0105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220590105%22">20590105 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Vaccines <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35941348 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41541-022-00515-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 91 Titles: – TitleFull: Author Correction: Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sánchez L – PersonEntity: Name: NameFull: Vidal M – PersonEntity: Name: NameFull: Jairoce C – PersonEntity: Name: NameFull: Aguilar R – PersonEntity: Name: NameFull: Ubillos I – PersonEntity: Name: NameFull: Cuamba I – PersonEntity: Name: NameFull: Nhabomba AJ – PersonEntity: Name: NameFull: Williams NA – PersonEntity: Name: NameFull: Díez-Padrisa N – PersonEntity: Name: NameFull: Cavanagh D – PersonEntity: Name: NameFull: Angov E – PersonEntity: Name: NameFull: Coppel RL – PersonEntity: Name: NameFull: Gaur D – PersonEntity: Name: NameFull: Beeson JG – PersonEntity: Name: NameFull: Dutta S – PersonEntity: Name: NameFull: Aide P – PersonEntity: Name: NameFull: Campo JJ – PersonEntity: Name: NameFull: Moncunill G – PersonEntity: Name: NameFull: Dobaño C IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 08 Text: 2022 Aug 08 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2059-0105 Numbering: – Type: volume Value: 7 – Type: issue Value: 1 Titles: – TitleFull: NPJ vaccines Type: main |
| ResultId | 1 |
